HeartFlow Analysis vs physIQ Heart Rhythm and Respiratory Module
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a highly accurate, non-invasive diagnostic assessment of coronary artery disease (CAD) based on standard CT scans. This tool is ideal for evaluating the functional significance of coronary stenoses and quantifying plaque burden to guide treatment decisions without the need for invasive procedures.
View HeartFlow Analysis →Choose physIQ Heart Rhythm and Respiratory Module if…
Choose physIQ Heart Rhythm and Respiratory Module if you need continuous, remote monitoring of a patient's physiological status using wearable biosensors. This platform is best suited for detecting subtle changes in heart rhythm and respiration, identifying early signs of decompensation, and providing personalized insights for managing chronic conditions or post-acute care.
View physIQ Heart Rhythm and Respiratory Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | physIQ Heart Rhythm and Respiratory Module |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS) | Cloud-based platform |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HeartFlow AnalysisHeartFlow Analysis simplifies a complex diagnostic process by creating personalized 3D models and FFRct values from standard CT scans, offering a clear visual aid for cardiologists and radiologists. While physIQ's platform for continuous monitoring is also designed for clarity, HeartFlow's ability to distill intricate anatomical and physiological data into actionable insights for a specific diagnostic decision likely provides a more streamlined and impactful user experience for its specialized users.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis demonstrates superior clinical value with extensive evidence from large, randomized trials (e.g., PRECISE, FISH&CHIPS) showing high diagnostic accuracy, significant reductions in cardiovascular mortality and all-cause mortality, and a substantial decrease in unnecessary invasive procedures for coronary artery disease. While physIQ offers valuable continuous monitoring for early decompensation and AF detection, HeartFlow's impact on hard clinical endpoints and its ability to guide definitive treatment decisions for a critical condition are more comprehensively documented.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis clearly outlines its fee-for-service model, supported by established Category I CPT codes and coverage from Medicare and most U.S. commercial payers, which provides a transparent and predictable reimbursement pathway for healthcare providers. In contrast, physIQ's pricing is listed as 'contact for pricing' with no specific reimbursement codes mentioned, making its financial value proposition less clear for potential adopters.
Enterprise Readiness
TieBoth HeartFlow Analysis and physIQ Heart Rhythm and Respiratory Module are cloud-based, FDA-cleared, HIPAA-compliant, and have Business Associate Agreements (BAAs) in place. HeartFlow is a commercial-stage company, and physIQ explicitly states its platform is 'enterprise-ready,' indicating comparable foundational capabilities for secure and scalable deployment within healthcare enterprises.
Innovation
HeartFlow AnalysisHeartFlow Analysis pioneered the use of AI-powered 3D modeling and Computational Fluid Dynamics to derive Fractional Flow Reserve from CT scans, representing a groundbreaking advancement in non-invasive coronary artery disease diagnosis. This innovation has been recognized with awards such as 'Fast Company's Most Innovative Companies in Medical Devices' and the 'Innovation in Cardiac Imaging award.' While physIQ's personalized physiology analytics are also innovative for continuous monitoring, HeartFlow's solution introduced a paradigm shift in cardiac diagnostics.
Support & Docs
TieThe provided structured facts and supplementary web searches do not offer specific details regarding the availability, scope, or quality of support and documentation for either HeartFlow Analysis or physIQ Heart Rhythm and Respiratory Module. Therefore, it is not possible to determine a winner for this dimension based on the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | physIQ Heart Rhythm and Respiratory Module |
|---|---|---|
| Company | HeartFlow | physIQ |
| Tagline | Decisive Coronary Care | The leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. |
| Description | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | Leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. Its industry-leading, enterprise-ready cloud platform continuously collects and processes data from any wearable biosensor using a deep portfolio of FDA-cleared analytics. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | AI-based personalized physiology analytics, Continuous wearable biosensor data collection, FDA-cleared analytics and digital biomarkers, Learns individual patient baseline, Detects subtle physiological changes and early signs of decompensation, Calculates heart rate and heart rate variability, Detects atrial fibrillation, Determines respiration rate |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and physIQ Heart Rhythm and Respiratory Module.